SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the March 2022 quarter is pegged at Rs. 13043.10 millions, about 12.71% up against Rs. 11572.40 millions recorded during the year-ago period.Modest increase of 8.77% in the Net Profit was reported from. 2311.10 millions to Rs. 2513.70  millions.The company reported a degrowth in operating Profit to 3029.00 millions from 3250.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 13043.10 11572.40 12.71 49966.00 50514.40 -1.09 49966.00 50514.40 -1.09
Other Income 116.00 247.40 -53.11 499.80 835.20 -40.16 499.80 835.20 -40.16
PBIDT 3029.00 3250.20 -6.81 11044.30 15819.70 -30.19 11044.30 15819.70 -30.19
Interest 59.20 21.40 176.64 166.70 127.70 30.54 166.70 127.70 30.54
PBDT 2969.80 3228.80 -8.02 10877.60 15692.00 -30.68 10877.60 15692.00 -30.68
Depreciation 459.50 418.40 9.82 1793.10 1526.00 17.50 1793.10 1526.00 17.50
PBT 2510.30 2810.40 -10.68 9084.50 14166.00 -35.87 9084.50 14166.00 -35.87
TAX -3.40 499.30 -100.68 1144.50 2412.10 -52.55 1144.50 2412.10 -52.55
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 2513.70 2311.10 8.77 7940.00 11753.90 -32.45 7940.00 11753.90 -32.45
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 23.22 28.09 -17.31 22.10 31.32 -29.42 22.10 31.32 -29.42

Alembic Pharma Share Price

785.40 8.05 (1.04%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×